Kim E. Nichols

25.1k total citations · 5 hit papers
221 papers, 12.6k citations indexed

About

Kim E. Nichols is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Kim E. Nichols has authored 221 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Immunology, 62 papers in Oncology and 62 papers in Hematology. Recurrent topics in Kim E. Nichols's work include Immune Cell Function and Interaction (87 papers), Autoimmune and Inflammatory Disorders Research (47 papers) and T-cell and B-cell Immunology (37 papers). Kim E. Nichols is often cited by papers focused on Immune Cell Function and Interaction (87 papers), Autoimmune and Inflammatory Disorders Research (47 papers) and T-cell and B-cell Immunology (37 papers). Kim E. Nichols collaborates with scholars based in United States, Canada and Germany. Kim E. Nichols's co-authors include Stuart G. Tangye, Carl H. June, James L. Riley, Jens M. Chemnitz, Richard V. Parry, Sabrin Albeituni, S. Cindy, Gary A. Koretzky, Randy Q. Cron and Courtney B. Crayne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Kim E. Nichols

216 papers receiving 12.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation

2004 927 citations Kim E. Nichols et al. profile →
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing

2006 618 citations Kim E. Nichols et al. profile →
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

2019 598 citations Paul La Rosée, AnnaCarin Horne et al. Blood profile →
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

2013 459 citations David T. Teachey, Susan R. Rheingold et al. Blood profile →
The Immunology of Macrophage Activation Syndrome

2019 424 citations Sabrin Albeituni, Kim E. Nichols et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim E. Nichols United States	58	6.7k	3.6k	3.1k	2.9k	1.9k	221	12.6k
Crystal L. Mackall United States	61	8.5k 1.3×	2.3k 0.6×	7.1k 2.3×	3.2k 1.1×	791 0.4×	168	16.1k
Susan F. Leitman United States	58	7.1k 1.1×	5.2k 1.4×	5.8k 1.9×	2.7k 0.9×	664 0.3×	225	16.1k
Andrew R. Gennery United Kingdom	51	3.9k 0.6×	2.3k 0.6×	1.5k 0.5×	2.7k 0.9×	894 0.5×	250	8.8k
Rupert Handgretinger Germany	70	7.0k 1.0×	6.4k 1.8×	5.4k 1.7×	5.3k 1.8×	1.0k 0.5×	493	19.0k
Toshihiro Miyamoto Japan	49	6.0k 0.9×	5.8k 1.6×	3.2k 1.0×	4.2k 1.4×	522 0.3×	359	13.7k
Eckhard Thiel Germany	57	3.4k 0.5×	2.5k 0.7×	3.1k 1.0×	3.1k 1.0×	1.0k 0.5×	260	11.9k
Arjan C. Lankester Netherlands	50	3.0k 0.4×	2.7k 0.8×	2.1k 0.7×	1.5k 0.5×	670 0.4×	231	7.8k
Richard Childs United States	57	4.6k 0.7×	4.6k 1.3×	3.8k 1.2×	2.3k 0.8×	410 0.2×	273	10.7k
Luigi D. Notarangelo United States	70	11.6k 1.7×	2.1k 0.6×	3.2k 1.0×	4.1k 1.4×	1.3k 0.7×	371	18.2k
Thomas Klingebiel Germany	55	2.6k 0.4×	4.3k 1.2×	3.1k 1.0×	1.5k 0.5×	717 0.4×	305	10.0k

Countries citing papers authored by Kim E. Nichols

Since Specialization

Citations

This map shows the geographic impact of Kim E. Nichols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim E. Nichols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim E. Nichols more than expected).

Fields of papers citing papers by Kim E. Nichols

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim E. Nichols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim E. Nichols. The network helps show where Kim E. Nichols may publish in the future.

Co-authorship network of co-authors of Kim E. Nichols

This figure shows the co-authorship network connecting the top 25 collaborators of Kim E. Nichols. A scholar is included among the top collaborators of Kim E. Nichols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim E. Nichols. Kim E. Nichols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meyer, Lauren K., Jerry C. Lee, Joseph M. Rocco, & Kim E. Nichols. (2025). Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy. Haematologica. 110(11). 2572–2587. 1 indexed citations

Brodeur, Garrett M., Lisa Diller, Kim E. Nichols, et al.. (2025). Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions. Clinical Cancer Research. 31(13). 2581–2588. 1 indexed citations

Zhang, Kejian, Lauren K. Meyer, Rafał Machowicz, et al.. (2025). Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH). Hematology/Oncology Clinics of North America. 39(3). 531–551. 1 indexed citations

Maese, Luke, Marcin W. Włodarski, Alison A. Bertuch, et al.. (2024). Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy. Clinical Cancer Research. 30(19). 4286–4295. 3 indexed citations

Kratz, Christian P., Philip J. Lupo, Kristin Zelley, et al.. (2024). Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents—To Test or not to Test?. Clinical Cancer Research. 30(9). 1733–1738. 9 indexed citations

Harrison, Lynn, et al.. (2024). Playing Russian Roulette: Parent and Adolescent Perspectives on Tumor Surveillance for Adolescents with Cancer Predisposition Syndromes. Clinical Cancer Research. 30(17). 3845–3854. 1 indexed citations

Albeituni, Sabrin, et al.. (2023). Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis. Frontiers in Immunology. 14. 1137037–1137037. 7 indexed citations

Sharp, Katianne M. Howard, Chen Li, Zhaohua Lu, et al.. (2023). Parent Quality of Life After Disclosure of Pediatric Oncology Germline Sequencing Results. JCO Precision Oncology. 7(7). e2300159–e2300159. 6 indexed citations

Oak, Ninad, Ruopeng Feng, Ilaria Iacobucci, et al.. (2023). ETV6 represses inflammatory response genes and regulates HSPC function during stress hematopoiesis in mice. Blood Advances. 7(18). 5608–5623. 9 indexed citations

10.

McGee, Rose B., Ninad Oak, Lynn Harrison, et al.. (2023). Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management. Clinical Cancer Research. 29(7). 1243–1251. 9 indexed citations

11.

MacFarland, Suzanne P., Luke Maese, Surya P. Rednam, et al.. (2022). Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition. Cancer Prevention Research. 15(10). 645–652. 3 indexed citations

12.

Johnson, Liza‐Marie, Belinda N. Mandrell, Chen Li, et al.. (2022). Managing Pandora’s Box: Familial Expectations around the Return of (Future) Germline Results. AJOB Empirical Bioethics. 13(3). 152–165. 9 indexed citations

13.

Meyer, Lauren K., Katherine Verbist, Sabrin Albeituni, et al.. (2020). JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation. Blood. 136(6). 657–668. 73 indexed citations

14.

Rosée, Paul La, AnnaCarin Horne, Melissa Hines, et al.. (2019). Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 133(23). 2465–2477. 598 indexed citations breakdown →

15.

Wang, Zhaoming, Qi Liu, Carmen L. Wilson, et al.. (2018). Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE). Clinical Cancer Research. 24(24). 6230–6235. 18 indexed citations

16.

Das, Rupali, Peng Guan, Leslee Sprague, et al.. (2016). Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood. 127(13). 1666–1675. 182 indexed citations

17.

Okumura, Mariko, Chin‐Jung Hsu, Hamid Bassiri, et al.. (2013). Murine natural killer immunoreceptors use distinct proximal signaling complexes to direct cell function. Blood. 121(16). 3135–3146. 25 indexed citations

18.

Bassiri, Hamid, Rupali Das, Peng Guan, et al.. (2013). iNKT Cell Cytotoxic Responses Control T-Lymphoma Growth In Vitro and In Vivo. Cancer Immunology Research. 2(1). 59–69. 47 indexed citations

19.

Teachey, David T., Susan R. Rheingold, Shannon L. Maude, et al.. (2013). Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy. Blood. 121(26). 5154–5157. 459 indexed citations breakdown →

20.

Palendira, Umaimainthan, Andrew Bell, S. Cindy, et al.. (2012). Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. The Journal of Experimental Medicine. 209(5). 913–924. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact